Development and characterization of hyaluronic acid surface scaffolds Encorafenib loaded polymeric nanoparticles for colorectal cancer targeting
For treatment of colorectal cancer and to improve intravascular bioavailability, Encorafenib
(ECF) encapsulated Hyaluronic Acid (HA) decorated polycaprolactone (PCL), and …
(ECF) encapsulated Hyaluronic Acid (HA) decorated polycaprolactone (PCL), and …
Molecular basis and clinical application of targeted therapy in oncology
T Tilak, A Patel, A Kapoor - Medical Journal Armed Forces India, 2023 - Elsevier
Targeted therapy and precision oncology aim to improve efficacy and minimize side effects
by targeting specific molecules involved in cancer growth and spread. With the …
by targeting specific molecules involved in cancer growth and spread. With the …
QbD Enabled Development and Evaluation of Pazopanib Loaded Nanoliposomes for PDAC Treatment
A Shinde, K Panchal, P Patra, S Singh, S Enakolla… - AAPS …, 2024 - Springer
Pancreatic ductal adenocarcinoma (PDAC) is one of the highly fatal types of cancer with
high mortality/incidence. Considering the crucial role of vascular endothelial growth factor …
high mortality/incidence. Considering the crucial role of vascular endothelial growth factor …
[HTML][HTML] Identification of the Major Degradation Pathways of Selumetinib
TS Bouchema, M Annereau, V Vieillard, R Boquet… - Pharmaceutics, 2022 - mdpi.com
Selumetinib is administered orally in capsule form and is indicated for the treatment of
neurofibromatosis. To facilitate dosage adjustments, liquid preparations, such as solutions …
neurofibromatosis. To facilitate dosage adjustments, liquid preparations, such as solutions …
Identification of the Major Degradation Pathways of Selumetinib.
M Annereau, V Vieillard, R Boquet… - …, 2022 - search.ebscohost.com
Selumetinib is administered orally in capsule form and is indicated for the treatment of
neurofibromatosis. To facilitate dosage adjustments, liquid preparations, such as solutions …
neurofibromatosis. To facilitate dosage adjustments, liquid preparations, such as solutions …
[HTML][HTML] Effect of macrocytosis on erlotinib response in metastatic non-small cell lung cancer: Macrocytosis with erlotinib in non-small cell lung cancer
SN Kazaz, ME Duygulu - Journal of Surgery and Medicine, 2023 - jsurgmed.com
Background/Aim: Numerous studies have assessed the relationship between macrocytosis
and responses to chemotherapeutic agents and TKIs such as sunitinib and imatinib …
and responses to chemotherapeutic agents and TKIs such as sunitinib and imatinib …
The Functional Role of SRMS in Conferring Platinum Resistance in Ovarian Cancer
Y Jiang - 2022 - search.proquest.com
i THE FUNCTIONAL ROLE OF SRMS IN CONFERRING PLATINUM RESISTANCE IN OVARIAN
CANCER A DISSERTATION Presented to the Faculty of The Page 1 i THE FUNCTIONAL …
CANCER A DISSERTATION Presented to the Faculty of The Page 1 i THE FUNCTIONAL …
Effect of macrocytosis on erlotinib response in metastatic non-small cell lung cancer.
SN Kazaz, ME Duygulu - Journal of Surgery & Medicine …, 2023 - search.ebscohost.com
Abstract Background/Aim: Numerous studies have assessed the relationship between
macrocytosis and responses to chemotherapeutic agents and TKIs such as sunitinib and …
macrocytosis and responses to chemotherapeutic agents and TKIs such as sunitinib and …